Alexander Kuo, MD

Alexander Kuo, MD

University of California San Diego Health System

Associate Professor of Clinical Medicine
Medical Director, Liver Transplant Program
UC San Diego Health System
La Jolla, California

Committees and Organizations

  • American College of Clinical Pharmacology 2012 Meeting Co-Chair, HCV Symposium (with Shirley Tsunoda, PharmD)

Honors and Awards

  • UCSD Gastroenterology Fellows Excellence in Clinical Teaching Award (2009-2010)

Selected Publications

  1. Kuo A, Dienstag JL, Chung RT. Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B. Clin Gastroenterol Hepatol. 2004;2:266-272.
  2. Kuo A, Terrault NA. Management of hepatitis C in liver transplant recipients. Am J Transplant. 2006;6:449-458.
  3. Kuo A, Terrault NA. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters? J Hepatol. 2007;46:359-361.
  4. Kuo A, Tan V, Lan B, et al. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008;14:1491-1497.
  5. Kuo A, Terrault NA. Is recurrent hepatitis C worse with living donors? Curr Opin Organ Transplant. 2009;14:240-244.
  6. Kuo A, Terrault NA. Hepatitis C and living donor liver transplantation. In: Mukherjee S, ed. Hepatitis C and liver transplantation. Nova Science Publishers; 2010:115-125.
  7. Kuo A, Gish R. Chronic hepatitis B infection. Clin Liv Dis. 2012 May;16(2):347-369.